Glenmark Life Sciences Ltd
BSE:543322
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Glenmark Life Sciences Ltd
BSE:543322
|
IN |
|
A
|
Arix Bioscience PLC
F:3HY
|
UK |
|
A
|
Amerisafe Inc
F:A3I
|
US |
|
Ulisse Biomed Spa
MIL:UBM
|
IT |
Wall St Price Targets
GLS Price Targets Summary
Glenmark Life Sciences Ltd
According to Wall Street analysts, the average 1-year price target for GLS is 1 225.77 INR with a low forecast of 1 186.33 INR and a high forecast of 1 295.5 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GLS's stock price target?
Price Target
1 225.77
INR
According to Wall Street analysts, the average 1-year price target for GLS is 1 225.77 INR with a low forecast of 1 186.33 INR and a high forecast of 1 295.5 INR.
What is the Revenue forecast for Glenmark Life Sciences Ltd?
Projected CAGR
12%
Over the last 4 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for Glenmark Life Sciences Ltd?
Projected CAGR
12%
Over the last 4 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Glenmark Life Sciences Ltd?
Projected CAGR
15%
Over the last 4 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 15%.
